FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

 
Share
 

Manage episode 200758342 series 1452688
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.

Released May 30, 2017.

135 episodes available. A new episode about every 33 days averaging 0 mins duration .